MASI vs. ITGR, TMDX, LIVN, CNMD, RVMD, BPMC, JAZZ, ENSG, HQY, and EXEL
Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), TransMedics Group (TMDX), LivaNova (LIVN), CONMED (CNMD), Revolution Medicines (RVMD), Blueprint Medicines (BPMC), Jazz Pharmaceuticals (JAZZ), The Ensign Group (ENSG), HealthEquity (HQY), and Exelixis (EXEL). These companies are all part of the "medical" sector.
Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, community ranking, earnings, institutional ownership, analyst recommendations, risk and profitability.
Masimo received 76 more outperform votes than Integer when rated by MarketBeat users. Likewise, 63.84% of users gave Masimo an outperform vote while only 63.41% of users gave Integer an outperform vote.
99.3% of Integer shares are owned by institutional investors. Comparatively, 86.0% of Masimo shares are owned by institutional investors. 2.0% of Integer shares are owned by company insiders. Comparatively, 9.7% of Masimo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Integer has higher earnings, but lower revenue than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
Integer has a net margin of 6.01% compared to Integer's net margin of 4.01%. Integer's return on equity of 13.26% beat Masimo's return on equity.
Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500.
Integer currently has a consensus price target of $128.00, suggesting a potential upside of 5.24%. Masimo has a consensus price target of $138.71, suggesting a potential upside of 9.94%. Given Integer's higher possible upside, analysts clearly believe Masimo is more favorable than Integer.
In the previous week, Masimo had 8 more articles in the media than Integer. MarketBeat recorded 11 mentions for Masimo and 3 mentions for Integer. Masimo's average media sentiment score of 0.74 beat Integer's score of 0.71 indicating that Integer is being referred to more favorably in the media.
Summary
Masimo beats Integer on 10 of the 18 factors compared between the two stocks.
Get Masimo News Delivered to You Automatically
Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
